EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia

Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni

Monaldi Archives for Chest Disease · 2024

DOI: 10.4081/monaldi.2024.3028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monaldi Archives for Chest Disease, 2024. Verfasst von Luigi Pinto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). Hauptthemen laut MEDLINE: COVID-19, Lung Diseases, Interstitial, Pulmonary Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following the onset of the new COVID-19 pandemic, particular attention is paid to the long-term outcomes, especially concerning patients affected by the SARS-CoV-2 virus, leading to interstitial pneumonia. The aim of this research is to evaluate the possible evolution over time of interstitial pneumonia into post-inflammatory fibrosing interstitial disease. This research included 42 patients admitted to the COVID ward for SARS-CoV-2 interstitial pneumonia, 10 patients with mild pneumonia and respiratory failure who were treated with O2 only, 32 patients with severe pneumonia in whom O2 and non-invasive ventilation were used for respiratory assistance, and 4 patients treated with invasive mechanical ventilation. At 70±30 days, 6, 12, 24, and 36 months after discharge, the cohort of patients underwent the evaluation of inflammation indices, high-resolution computed tomography (CT) chest scans, and functional respiratory tests. The comparative analysis showed that 83.3% of patients had residual parenchymal lung disease at 36-month follow-up, with a significantly higher rate in those with severe pneumonia and more extensive disease on initial CT. Regarding the pulmonary involvement model, patients presented ground-glass opacity or peripheral parenchymal bands, or a combination of them, and peri- and intralobular interstitial thickening, which may be representative of fibrotic interstitial lung disease. There is a correlation between the severity of pneumonia, the inflammatory state, the need to increase respiratory support, and the quantity and persistence of CT-related lesions. Reductions in respiratory functions and exercise capacity were observed, the latter more pronounced in patients (24%) who had contracted severe pneumonia and required ventilatory support. Pulmonary outcomes from SARS-CoV-2 respiratory infections show a wide range of radiological findings, from complete recovery to stable outcomes of thickening and distortion of the interstitial architecture. From a functional point of view, there is an impairment of the alveolar-capillary diffusion capacity and, in cases of those who had contracted severe pneumonia, desaturation and reduced exercise tolerance in 24% of cases at a 36-month follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Lung Diseases, InterstitialPulmonary FibrosisHumansMaleFemaleMiddle AgedTomography, X-Ray ComputedAgedSARS-CoV-2LungRespiration, ArtificialSeverity of Illness IndexRespiratory Function TestsRespiratory Insufficiency

Stichwörter der Autor:innen

COVID-19 interstitial pneumoniapulmonary fibrosis

Autor:innen und Institutionen

  • Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA).
  • Radiology Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA).
  • Unit of Internal Medicine, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA).

Zitieren

APA

Pinto, L., Schino, P., Bitetto, M., Tedeschi, E., Maiellari, M., De Leo, G., Ludovico, E., Larizza, G., & Mastroianni, F. (2024). Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2024.3028

Vancouver

Pinto L, Schino P, Bitetto M, Tedeschi E, Maiellari M, De Leo G, et al. Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia. Monaldi Archives for Chest Disease. 2024. doi:10.4081/monaldi.2024.3028

BibTeX
@article{Pinto2024,
  author = {Pinto, Luigi and Schino, Pietro and Bitetto, Michele and Tedeschi, Ersilia and Maiellari, Michele and De Leo, Giancarlo and Ludovico, Elena and Larizza, Giovanni and Mastroianni, Franco},
  title = {Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia},
  journal = {Monaldi Archives for Chest Disease},
  year = {2024},
  doi = {10.4081/monaldi.2024.3028}
}
Kostenlos starten →